Related Experiment Video

Updated: Aug 7, 2026

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

A direct mechanistic link between growth control and a tumor cell immune function: increased interleukin-8 secretion

Kimberly M Palubin1, Bonnie L Goodwin, Melissa I Niesen

  • 1Department of Molecular Medicine and College of Medicine, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida 33612, USA.

Anticancer Research
|July 11, 2006
PubMed
Abstract

Insights

Oct-1 protein regulates cell growth and immune responses. Inhibiting Oct-1 reduced tumor cell growth and increased immune gene expression, linking growth control and tumor immunity.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Immunology

Background:

  • Tumorigenesis involves dysregulated proteins like Oct-1, a transcription factor controlling cell growth.
  • Oct-1 activates genes for S-phase and cell growth, including histone H2B and snRNPs.
  • Oct-1 also represses immune genes such as IL-8 and HLA-DRA.

Purpose of the Study:

  • To investigate the role of Oct-1 in tumor cell growth and immune function.
  • To determine the link between growth control deregulation and tumorigenicity.

Main Methods:

  • Oct-1 antisense technology was used to create transformants with reduced Oct-1 levels.
  • Growth rates of Oct-1 antisense transformants were analyzed.
  • Tumor cell survival and immune gene expression (IL-8) were assessed in scid mice.

Main Results:

  • Oct-1 antisense transformants exhibited reduced growth rates.
  • These transformants had a shorter survival time in scid mice.
  • Increased IL-8 expression was observed in Oct-1 antisense transformants, correlating with reduced survival.

Conclusions:

  • Growth control deregulation alone is insufficient for tumorigenicity.
  • Molecular mechanisms of growth control and tumor cell immune functions are interconnected.
  • Oct-1 plays a critical role in linking cell growth and immune evasion in tumors.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...